SUMMARY
This is a retrospective chart review of a systematic sample of 200 persons identified as diabetic who were incarcerated in the San Francisco County Jail in 2003 out of approximately 55,000 annual admissions. Of the 424 inmates identified with diabetes, 200 underwent a detailed chart review. Inmate care achieved a score of greater than 90% in five out of nine quality-of-care indicators. Greater adherence to quality measures was found in inmates with longer jail stays. The authors conclude that quality diabetes care can be provided using a protocol-driven approach based on American Diabetes Association and National Commission on Correctional Health Care guidelines. They also conclude that jails can play an important role in improving health care for poor and minority populations with both initiation of chronic disease evaluation and management and education. The authors call for improved links between jails, public health systems, and other healthcare providers.
COMMENTARY
Although there were relatively few diabetics incarcerated in the San Francisco County Jail, it is clear that quality care in the incarcerated setting is possible. It is not clear how representative the San Francisco County Jail is of other jails around the nation, but at least it is something that other jails can be measured up against. In order to capitalize on the public health benefit of incarceration, appropriate linkages to care after incarceration are crucial, in addition to designing and implementing protocols to provide high-quality care. 
SUMMARY
The authors describe a pilot study to access the feasibility of identifying injection drug users with acute HIV in correctional and detoxification facilities. They educated onsite medical providers regarding risk factors, signs, and symptoms of hepatitis infection, and gave instructions to refer potential cases to the specialty clinic. Over a 30-month period, 21 patients were diagnosed with acute hepatitis C. Of 17 patients observed for a mean duration of 6.3 months, eight had spontaneous virologic clearance. Early therapy with pegylated interferon was initiated for five patients with persistent viremia and led to sustained virologic response in two individuals. The authors concluded that incarceration presents a unique opportunity to identify injection drug users with acute hepatitis C infection to initiate counseling and immunization and hepatitis C treatment.
COMMENTARY
Individuals with drug addiction often, due to the nature of addiction, increase their drug use in parallel with illegal activities and increased risky behaviors for infection, such as sharing contaminated injection equipment. Thus, it is not surprising to imagine that, at the time of incarceration, many individuals will have recently been infected with blood-borne pathogens. Approximately one-third of all inmates in the USA have chronic hepatitis C infection and more than one million HCV-infected individuals are released from incarceration each year. Thus, nearly half of all individuals with HCV infection in the USA are either incarcerated or released from incarceration each year. In the accompanying editorial by Thomas, he highlights the importance of the Bwindow of opportunity^to diagnose, treat, and prevent hepatitis C infection in the incarcerated setting; however, he notes that often Bthis window is barred for inmates.^Clearly, if we are going to address hepatitis C in a comprehensive manner, a correctional setting will be key. 2 on entry into prison as characteristics associated with HIV seroconverstion. The accompanying editorial recommends HIV education, testing, and prevention counseling, as well as linkage to HIVspecific care for those who are positive both while incarcerated and after release. Departments of corrections were also encouraged to evaluate the feasibility and benefits of implementing condom distribution for inmates.
